Characteristics | PedsQL (children’s score) | PedsQL (parents’ score) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Generic mean (sd) | p-value | Cancer mean (sd) | p-value | Fatigue mean (sd) | p-value | Generic mean (sd) | p-value | Cancer mean (sd) | p-value | Fatigue mean (sd) | p-value |
Gender distribution | ||||||||||||
 Female | 68.8(11.0) | 0.73 | 69.6(12.1) | 0.17 | 77.1(14.2) | 0.98 | 55.5(16.6) | 0.09 | 68.6(12.2) | 0.58 | 72.8(22.4) | 0.57 |
 Male | 66.0(13.3) |  | 70.4(11.2) |  | 75.5(13.8) |  | 66.9(16.4) |  | 66.6(14.2) |  | 77.9(17.7) |  |
Age groups | ||||||||||||
 2 to 4 years |  |  |  |  |  |  | 69.6(21.7) |  | 67.9(13.6) |  | 77.3(26.5) |  |
 5 to 12 years | 70.9(11.3) | 0.13 | 66.8(12.2) | 0.34 | 77.9(14.4) | 0.68 | 58.1(15.4) | 0.52 | 66.9(13.6) | 0.99 | 78.6(19.1) | 0.40 |
 13 to 18 years | 63.5(12.6) |  | 73.1(9.9) |  | 74.4(13.3) |  | 60.7(12.6) |  | 67.3(14.1) |  | 72.4(10.7) |  |
Diagnostic groups | ||||||||||||
 Leukaemia | 68.4(12.3) | 0.63 | 73.2(8.7) | 0.11 | 77.0(13.5) | 0.36 | 63.8(16.8) | 0.68 | 69.3(13.9) | 0.37 | 77.1(18.9) | 0.08 |
 Solid tumours | 66.7(15.3) |  | 70.6(7.7) |  | 79.1(15.1) |  | 63.1(22.6) |  | 62.3(9.3) |  | 83.1(7.0) |  |
 CNS tumours | 59.8(1.5) |  | 50.5(17.7) |  | 63.2(6.2) |  | 54.7(10.4) |  | 63.7(16.6) |  | 54.6(16.1) |  |
Treatment modality | ||||||||||||
 Chemotherapy | 70.4(12.4) | 0.09 | 73.8(8.3) | 0.01 | 80.7(11.4) | 0.01 | 65.8(17.1) | 0.04 | 69.0(13.1) | 0.12 | 79.2(18.5) | 0.02 |
 Combined therapy | 58.7(7.8) |  | 59.6(12.7) |  | 63.2(11.3) |  | 47.4(4.2) |  | 59.3(12.4) |  | 59.7(15.7) |  |